Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-01

Clinical Trial Update: A Study of XS-02 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers XS-02 capsules in advanced solid tumors (including ovarian, breast, and endometrial cancers) in Phase 1/2, with status not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XS-02 (XS-02)

Snippet

Sponsor: NovaOnco Therapeutics Co., Ltd. | Conditions: Solid Tumor, Ovarian Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING